Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trial
Understanding the medication's established safety profile and distinguishing between common side effects and symptoms requiring medical evaluation is essential for anyone considering or currently using this treatment
7,8 Many case series, however, diagnosed AIG solely based on serological markers such as IFAs or PCAs, pepsinogen levels or gastrin-17, without confirmatory biopsy
The prepared sections were examined under a light microscope (Olympus, Japan)
In the context of T2D, caloric restriction alleviates oxidative stress and inflammation, as does autophagy
Results Immunolocalization of the Reduced Form of Glutathione in Wild-Type and Mutant Nodules In wild-type nodules (Figures 1AC), GSH was detected in the cytoplasm and nuclei of meristematic cells (Figures 1DF), the cytoplasm and nuclei of infected cells in the infection zone (Figures 1GI), the cytoplasm and symbiosomes of cells in the nitrogen fixation zone (Figures 1JL), and cells of the nodule parenchyma and vascular tissue (Figures 1AC)